| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $3,089,125 ) |
| | 2023 | 2023 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01HL160972 | Investigate the role of extracellular vesicles in promoting the progression of pulmonary lymphangioleiomyomatosis | 000 | 2 | NIH | 11/23/2022 | $629,514 |
| | 2023 | 2023 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01NS038261 | Amygdala pain mechanisms | 000 | 24 | NIH | 12/22/2022 | $496,430 |
| | 2023 | 2023 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | H8G48162 | FY 2023 Expanding COVID-19 Vaccination | 00 | 1 | HRSA | 12/7/2022 | $138,595 |
| | 2023 | 2023 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R21CA277140 | Amino acid transporter SLC38A5 as a drug target for TNBC: Evaluation with genetic and pharmacologic approaches | 000 | 1 | NIH | 12/16/2022 | $214,583 |
| | 2023 | 2023 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01NS077114 | Probing the structure and function of the intracellular domain of cys-loop receptors | 001 | 7 | NIH | 11/30/2022 | $344,250 |
| | 2023 | 2023 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01HL157128 | Vascular dysfunction in coronary microcirculation | 000 | 2 | NIH | 11/17/2022 | $571,431 |
| | 2023 | 2023 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01AG071859 | Transcriptional Dysfunction in Dentate Gyrus Cell Types: Roles of Retinoic Acid Responsive Genes in Protection Against Alzheimer's Disease Pathogenesis | 000 | 2 | NIH | 1/11/2023 | $374,444 |
| | 2023 | 2023 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01CA264949 | Targeting Shared Vulnerabilities in Alternate Telomere Lengthening (ALT) Cancers | 000 | 2 | NIH | 1/19/2023 | $345,690 |
| | 2023 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | H8012853 | Health Center Cluster | 04 | 13 | HRSA | 10/5/2022 | $0 |
| | 2023 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | H4B15562 | Poison Control Stabilization and Enhancement Program | 01 | 14 | HRSA | 10/24/2022 | $0 |
| | 2023 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | U7716497 | Model State-Supported Area Health Education Centers | 02 | 14 | HRSA | 12/2/2022 | $0 |
| | 2023 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01NS077114 | Probing the structure and function of the intracellular domain of cys-loop receptors | 000 | 6 | NIH | 11/1/2022 | $116,390 |
| | 2023 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | T9D45837 | Primary Care Training and Enhancement: Physician Assistant Rural Training Program | 05 | 1 | HRSA | 11/8/2022 | $0 |
| | 2023 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | T9D45837 | Primary Care Training and Enhancement: Physician Assistant Rural Training Program | 04 | 1 | HRSA | 10/27/2022 | $0 |
| | 2023 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | U01AA028957 | Medication Development for the Treatment of Alcohol Use Disorder | 000 | 3 | NIH | 12/1/2022 | $0 |
| | 2023 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | UD737639 | Nurse Education, Practice, Quality, and Retention - Interprofessional Collborative Practice | 01 | 3 | HRSA | 11/1/2022 | $0 |
| | 2023 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | H8012853 | Health Center Cluster | 06 | 13 | HRSA | 12/6/2022 | $0 |
| | 2023 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | H8012853 | Health Center Cluster | 05 | 13 | HRSA | 10/7/2022 | $0 |
| | 2023 | 2020 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R56NS077114 | Probing the structure and function of the intracellular domain of cys-loop receptors | 000 | 6 | NIH | 11/1/2022 | -$116,390 |
| | 2023 | 2019 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R56AG060767 | Small Molecules as Therapeutic Targets for Alzheimer's Disease | 000 | 1 | NIH | 10/13/2022 | -$746 |
| | 2023 | 2018 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R15CA231339 | Novel Class of Chemotherapeutic Agents for Treatment of Metastatic Triple-negative Breast Cancer | 000 | 1 | NIH | 10/14/2022 | -$4,415 |
| | 2023 | 2018 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R21AI131696 | Modulation of Zika Virus Infection by Preexisting West Nile Virus Antibodies | 000 | 2 | NIH | 10/1/2022 | -$20,652 |
|
| Issue Date FY: 2022 ( Subtotal = $21,767,261 ) (Continued on the next page) |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01HL157128 | Vascular dysfunction in coronary microcirculation | 000 | 1 | NIH | 12/10/2021 | $634,922 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01CA232591 | MYC activation in tumor progression of neuroblastoma | 001 | 4 | NIH | 4/28/2022 | $29,841 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01CA232591 | MYC activation in tumor progression of neuroblastoma | 000 | 4 | NIH | 1/25/2022 | $335,731 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01NS106879 | Development and characterization of peptidomimetic small molecule activators of peptidase neurolysin for stroke therapy. | 000 | 5 | NIH | 8/8/2022 | $578,588 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01CA217251 | Alternate telomere maintenance mechanisms in high-risk neuroblastoma as prognostic indicators and therapeutic targets | 000 | 5 | NIH | 7/11/2022 | $342,988 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01AR068279 | Myeloid KLF2 regulation mechanisms in rheumatoid arthritis | 000 | 6 | NIH | 4/29/2022 | $333,234 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01NS077114 | Probing the structure and function of the intracellular domain of cys-loop receptors | 000 | 6 | NIH | 12/13/2021 | $382,500 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01NS038261 | Amygdala pain mechanisms | 003 | 23 | NIH | 6/8/2022 | $128,474 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01NS038261 | Amygdala pain mechanisms | 001 | 23 | NIH | 12/15/2021 | $551,588 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01NS117906 | Repurposing Metformin to Offset Stroke Risk and Injury in Comorbid Populations of Smokers | 000 | 3 | NIH | 5/27/2022 | $586,033 |
| | 2022 | 2022 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | H8F41662 | American Rescue Plan Act Funding for Health Centers | 01 | 1 | HRSA | 8/3/2022 | $65,500 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01GM141216 | Studies of P-glycoprotein drug interactions | 000 | 1 | NIH | 7/7/2022 | $319,190 |
| | 2022 | 2022 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | UD737639 | Nurse Education, Practice, Quality, and Retention - Interprofessional Collborative Practice | 00 | 3 | HRSA | 5/12/2022 | $494,124 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01AA027096 | The neuroimmune model of excessive alcohol consumption: Transition to Alcohol Use Disorder. | 000 | 5 | NIH | 7/1/2022 | $424,375 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01AA027096 | The neuroimmune model of excessive alcohol consumption: Transition to Alcohol Use Disorder. | 000 | 5 | NIH | 7/1/2022 | $49,375 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01AA027096 | The neuroimmune model of excessive alcohol consumption: Transition to Alcohol Use Disorder. | 000 | 5 | NIH | 7/1/2022 | $100,000 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01CA219187 | Hedgehog/GLI1-mediated regulation of DNA repair in cancer, aging and neurodegenerative diseases | 000 | 5 | NIH | 1/4/2022 | $290,368 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01CA219187 | Hedgehog/GLI1-mediated regulation of DNA repair in cancer, aging and neurodegenerative diseases | 001 | 5 | NIH | 4/28/2022 | $25,811 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01AG073826 | The hippocampal dentate gyrus in aging and Alzheimer's disease: boosting transcription of retinoic acid-sensitive genes through vitamin A supplementation and HDAC inhibition | 000 | 1 | NIH | 7/20/2022 | $636,809 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01CA219187 | Hedgehog/GLI1-mediated regulation of DNA repair in cancer, aging and neurodegenerative diseases | 002 | 5 | NIH | 6/28/2022 | $382,500 |
| | 2022 | 2022 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | D3445727 | Centers of Excellence | 00 | 1 | HRSA | 5/26/2022 | $685,999 |
| | 2022 | 2022 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | U1U42526 | Regional Telehealth Resource Centers | 00 | 2 | HRSA | 7/27/2022 | $325,000 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | T2946733 | Community Health Worker Training Program | 00 | 1 | HRSA | 9/7/2022 | $2,425,194 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01AG071859 | Transcriptional Dysfunction in Dentate Gyrus Cell Types: Roles of Retinoic Acid Responsive Genes in Protection Against Alzheimer's Disease Pathogenesis | 000 | 1 | NIH | 12/23/2021 | $374,444 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | RF1AG079264 | MicroRNA Mouse Models and Alzheimer?s Disease | 000 | 1 | NIH | 9/15/2022 | $1,862,337 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R21DA053824 | Alzheimer?s disease and chronic pain | 001 | 2 | NIH | 8/18/2022 | $382,500 |
|
